These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22179577)

  • 1. Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.
    Maeno S; Kondo F; Sano K; Takada T; Asano T
    J Hepatobiliary Pancreat Sci; 2012 May; 19(3):289-96. PubMed ID: 22179577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Cholangiolocellular Carcinoma: Possibility of an Interlobular Duct Origin.
    Kondo F; Fukusato T
    Intern Med; 2015; 54(14):1685-94. PubMed ID: 26179521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.
    Hoshino H; Ohta M; Ito M; Uchimura K; Sakai Y; Uehara T; Low S; Fukushima M; Kobayashi M
    Lab Invest; 2016 Dec; 96(12):1246-1255. PubMed ID: 27748735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
    Shibuya M; Kondo F; Sano K; Takada T; Asano T
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
    Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
    Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
    Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
    Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
    Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
    Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation.
    Kumagai A; Kondo F; Sano K; Inoue M; Fujii T; Hashimoto M; Watanabe M; Soejima Y; Ishida T; Tokairin T; Saito K; Sasajima Y; Takahashi Y; Uozaki H; Fukusato T
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):414-21. PubMed ID: 27161394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
    Xu J; Zhang C; Qiao A; Xi Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.
    Ono Y; Hiratsuka Y; Murata M; Takasawa A; Fukuda R; Nojima M; Tanaka S; Osanai M; Hirata K; Sawada N
    Virchows Arch; 2016 Oct; 469(4):417-26. PubMed ID: 27444172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of cholangiolocellular carcinoma combined with intrahepatic cholangiocarcinoma diagnosed after 4 years follow-up for hepatic hemangioma].
    Koga Y; Nagahama H; Tateyama M; Fukubayashi K; Kamiya Y; Tanaka M; Tashima R; Beppu T; Baba H; Iyama K; Sasaki Y
    Nihon Shokakibyo Gakkai Zasshi; 2012 Feb; 109(2):231-9. PubMed ID: 22306546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein.
    Yoh T; Kato T; Hirohata Y; Nakamura Y; Nakayama H; Okamura R
    Clin J Gastroenterol; 2016 Aug; 9(4):257-60. PubMed ID: 27363839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.
    Haradome H; Unno T; Morisaka H; Toda Y; Kwee TC; Kondo H; Sano K; Ichikawa T; Kondo F; Sugitani M; Takayama T
    Eur Radiol; 2017 Nov; 27(11):4461-4471. PubMed ID: 28439650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
    Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
    Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
    Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan.
    Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH
    Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
    Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
    Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
    Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.